West Pharmaceutical Services Inc at JPMorgan Healthcare Conference Transcript
Good morning, all, and welcome. My name is Fawzi Kawash, and I'll be moderating today's session. It is my pleasure to introduce Eric Green, President, CEO and Board Chair; Bob McMahon, CFO; and John Sweeney, VP of IR of West to the JPMorgan conference.
And without further ado, I'll hand it over to Eric.
All right. Fawzi, thank you so much for the introduction, and thank you for the invitation for the JPMorgan Conference. Happy New Year to everybody, and it's a great start to 2026. Before I get started into the West discussion, I want to just reference the safe harbor statement that's found on this presentation, also found at our website at westpharma.com. I'm going to talk a little bit about West.
It's a phenomenal story over several decades of where we are today, but more importantly, where we're going. If you think of from an investment portfolio perspective, we are the global leader in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

